CIK 0001889109 · Large accelerated filer
BELITE BIO, INC
Sign in to watch- Ticker
- BLTE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- other
- Phone
- 858-246-6240
- Business address
- 12750 HIGH BLUFF DRIVE SUITE 475, SAN DIEGO, CA, 92130
- Former names
- BELITE BIO, INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $31,968,735
- in 3 filings, $32.0M under 10b5-1 plans
Net −$31,968,735. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-16 | Scholl Hendrik Peter Chief Medical Officer | Sale | −784 | $138.18 | $108K | 32,162 |
| 2026-06-16 | Scholl Hendrik Peter Chief Medical Officer | Sale | −3,140 | $139.57 | $438K | 29,022 |
| 2026-06-16 | Scholl Hendrik Peter Chief Medical Officer | Sale | −540 | $140.58 | $76K | 28,482 |
| 2026-06-16 | Scholl Hendrik Peter Chief Medical Officer | Sale | −100 | $141.83 | $14K | 28,382 |
| 2026-06-16 | Scholl Hendrik Peter Chief Medical Officer | Sale | −450 | $142.20 | $64K | 27,932 |
| 2026-06-16 | Scholl Hendrik Peter Chief Medical Officer | Sale | −1,897 | $143.55 | $272K | 26,035 |
| 2026-06-16 | Scholl Hendrik Peter Chief Medical Officer | Sale | −1,035 | $145.02 | $150K | 25,000 |
| 2026-05-07 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −226 | $152.45 | $34K | 440 |
| 2026-05-07 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −428 | $153.56 | $66K | 12 |
| 2026-05-07 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −3 | $154.61 | $464 | 9 |
| 2026-05-07 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −9 | $155.25 | $1K | 0 |
| 2026-05-06 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −8 | $151.57 | $1K | 1,658 |
| 2026-05-06 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −424 | $152.67 | $65K | 1,234 |
| 2026-05-06 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −128 | $153.42 | $20K | 1,106 |
| 2026-05-06 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −240 | $154.41 | $37K | 866 |
| 2026-05-06 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −100 | $155.97 | $16K | 766 |
| 2026-05-06 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −100 | $156.00 | $16K | 666 |
| 2026-05-05 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −120 | $153.92 | $18K | 2,546 |
| 2026-05-05 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −363 | $154.44 | $56K | 2,183 |
| 2026-05-05 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −173 | $155.48 | $27K | 2,010 |
Page 4 of 10 · 186 trades